| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CEO
1 company
Derek T Chalmers last filed a Form 4 in September 2021, as President & CEO at TVRD. Derek T Chalmers's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 991,405 shares of TVRD. The TVRD filings lean toward selling, a net 416,442 shares.
Derek T Chalmers has 47 Form 4 filings on record from June 2015 to September 2021, all as President & CEO at Tvardi Therapeutics (TVRD), 2015–2021.
The 63 reported transactions were 42 open-market sales, 10 stock awards, 7 option or other derivative awards and 4 option exercises.
Counted by filing, the open-market trades come to no purchases and 37 sales worth about $7.2M.
The largest open-market sale was 20,000 shares of TVRD at an average $23.79 on October 1, 2018, about $476K.
Shares as reported in the last Form 4 for each company; the most recent is from September 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 20,000 | $15.47 | $309,400.00 | -2.0% | -22.3% | -29.8% | |
| Aug 30, 2021 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 8,440 | $14.20 | $119,848.00 | -0.8% | -15.2% | -29.8% | |
| Mar 5, 2021 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 3,103 | $17.98 | $55,791.94 | -0.3% | - | - | |
| Feb 25, 2021 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 11,729 | $19.33 | $226,721.57 | -1.2% | - | - | |
| Dec 30, 2020 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 6,078 | $15.30 | $92,993.40 | -0.6% | - | - | |
| Dec 28, 2020 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 5,000 | $16.00 | $80,000.00 | -0.5% | - | - | |
| Dec 16, 2020 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 5,000 | $14.95 | $74,750.00 | -0.5% | - | - | |
| Dec 10, 2020 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 7,500 | $15.29 | $114,675.00 | -0.8% | - | - | |
| Nov 17, 2020 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 11,799 | $16.00 | $188,784.00 | -1.2% | - | - | |
| Sep 3, 2020 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 3,201 | $16.00 | $51,216.00 | -0.3% | - | - |